NASDAQ · BIAF
bioAffinity Technologies, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BIAF: Nov 13, 2026
bioAffinity Technologies, Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-40.48.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks- RTTNews · Oct 9, 6:26 AM EDTBioAffinity Prices $4 Mln Direct Offering, Adds Warrants To Support CyPath Lung Sales(RTTNews) – bioAffinity Technologies Inc. (BIAF), a biotechnology company developing noninvasive tests for lung disease, has agreed to raise approximately $4 million through a registered direct offering, alongside a concurrent private placement of warrants.
- RTTNews · Sep 1, 10:40 PM EDT6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More(RTTNews) – Today's after-hours gainers in the healthcare sector included Universe Pharmaceuticals, which drew attention after disclosing multiple Schedule 13G filings; bioAffinity Technologies, which is exploring a new use for its CyPath Lung test in monitoring lung cancer patie
- RTTNews · Sep 1, 9:44 AM EDTBioAffinity Technologies Advances CyPath Lung; Stock Surge(RTTNews) – bioAffinity Technologies Inc. (BIAF) announced that it is advancing the application of its CyPath Lung test to support surveillance of lung cancer patients who have completed curative-intent treatment.
- RTTNews · Aug 19, 9:32 AM EDTBioAffinity And AvMEDICAL Sign Nationwide Federal Distribution Agreement Of CyPath Lung; Stock Down(RTTNews) – bioAffinity Technologies (BIAF), a biotechnology company focused on non-invasive diagnostics for the early detection of lung disease, announced a nationwide distribution agreement with AvMEDICAL, a Service-Disabled Veteran-Owned Small Business and established governme
- Zacks · Jul 24, 9:04 AM EDTBIAF vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?bioAffinity and Biodesix pursue different cancer diagnostics strategies, but which oncology stock offers better long-term upside? Let's dive in.
- Zacks · Jul 9, 1:34 PM EDTBIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?bioAffinity's CyPath Lung sales momentum is gaining traction, but wider losses, funding needs and regulatory risks keep pressure on the stock.
- Zacks · May 14, 10:27 AM EDTBIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath LungbioAffinity posts softer first-quarter 2026 results after exiting lower-margin pathology services, though CyPath Lung adoption and clinical-trial progress gain traction.
- Zacks · Apr 16, 9:55 AM EDTbioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?BIAF is sharpening its focus on CyPath Lung, streamlining unprofitable services and pushing validation studies as it expands its lung-disease pipeline.
- RTTNews · Apr 1, 9:54 AM EDTBioAffinity Soars On Strong Preliminary Sales Growth Of CyPath Lung Test(RTTNews) – Shares of bioAffinity Technologies Inc. (BIAF) are up over 10% in Wednesday's trading, after the company announced stronger-than-expected unit growth in the first quarter of 2026 for its noninvasive diagnostic test, CyPath Lung.
- RTTNews · Mar 17, 8:53 AM EDTBioAffinity Case Study Shows CyPath Lung Avoids Costly Biopsy; Stock Up(RTTNews) – bioAffinity Technologies, Inc. (BIAF) has released a new case study showing how its noninvasive diagnostic test, CyPath Lung, provided actionable results that helped a high-risk patient avoid an invasive lung biopsy.
- RTTNews · Mar 13, 9:34 AM EDTBioAffinity Technologies Surges On Launch Of Large-Scale Lung Cancer Study(RTTNews) – Shares of bioAffinity Technologies, Inc (BIAF) are up in the pre-market by 72% after the company announced the start of a major longitudinal clinical study evaluating noninvasive CyPath Lung diagnostic for early detection of lung cancer.
- Zacks · Mar 5, 11:51 AM ESTBIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?bioAffinity leans on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health expands liquid biopsy and screening. Which strategy is ahead? Let's see.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for bioAffinity Technologies, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.